retatrutide approval status 2025 🚨Breaking: Retatrutide's first Phase 3 T2D data just dropped. ▸ A1C: −2.0% at 40 weeks ▸ Weight: −36.6 lbs (−16.8%) at 12 mg ▸ No weight loss plateau — curve still descending Retatrutide FDA Approval 2025–2026: Phase

If the concentration is too low, the regeneration reaction remains incomplete, preventing the full restoration of the resin's exchange capacity

This means that anything you swallowfood, water, or pillsstays in your stomach longer than usual

Always discuss any new medications or supplements with a health professional, so you can make informed decisions that suit your individual needs and support lasting wellbeing

Ji X, Wang J, Lan T et al (2025a) Gut microbial metabolites and the braingut axis in alzheimers disease: A review

I see too many people jumping straight to subcutaneous injections at 1-2 mg daily without understanding the increased systemic exposure and copper burden that comes with them